Skip to main content
Livermore
Livermore
ZHEN

Immunovant, Inc.

IMVT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001764013

In the last 90 days, Immunovant, Inc. insiders filed 0 open-market purchases and 10 sales; 226 institutions reported holding it in 13F filings for Q2 2026, worth $4.25B in total; Greenlight Capital is the only superinvestor holding it.

Q2 2023 vs. Q1 2023

How the institutions holding Immunovant, Inc. changed between Q1 2023 and Q2 2023.

All holders in Q2 2023All holders in Q1 2023

13F holders of IMVT: Q1 2023 compared with Q2 2023
MeasureQ1 2023Q2 2023Change
Holders142147+5
Shares58.3M55.5M−2.80M (−4.8%)
Value$903.7M$1.05B+$148.2M (+16.4%)

New holders (29)

Institutions that held Immunovant, Inc. at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to IMVT in Q2 2023
InstitutionSharesValue% of portfolio
Pictet Asset Management SA580,170$11.0M0.01%
Cormorant Asset Management, LP550,000$10.4M0.59%
Skandinaviska Enskilda Banken AB (publ)521,084$9.88M0.06%
Point72 Asset Management, L.P.457,467$8.68M0.03%
Affinity Asset Advisors, LLC260,000$4.93M1.94%
Balyasny Asset Management LLC255,677$4.85M0.01%
Soleus Capital Management, L.P.173,599$3.29M0.37%
Readystate Asset Management LP143,100$2.71M0.27%
Acuta Capital Partners, LLC141,755$2.69M1.82%
Empowered Funds, LLC136,097$2.58M0.09%
EA Series Trust136,097$2.58M0.09%
Twinbeech Capital LP109,448$2.08M0.04%
Rhenman & Partners Asset Management AB100,000$1.90M0.20%
Neuberger Berman Group LLC77,787$1.48M0.00%
Mirabella Financial Services LLP69,573$1.32M0.15%
Seven Eight Capital, LP45,874$870.2K0.14%
EAM Investors, LLC39,796$754.9K0.14%
Altium Capital Management LP35,100$665.8K0.52%
Gsa Capital Partners LLP32,736$621.0K0.06%
Engineers Gate Manager LP26,519$503.1K0.02%
Aigen Investment Management, LP23,710$449.8K0.07%
Franklin Resources Inc22,379$424.5K0.00%
CoreCap Advisors, LLC15,412$292.4K0.02%
PEAK6 Investments LLC13,000$246.6K0.02%
Virtu Financial LLC10,461$198.0K0.02%
Aquatic Capital Management LLC2,300$44.0K0.00%
Impact Partnership Wealth, LLC94$1.78K0.00%
Gradient Investments LLC2$380.00%
CWM, LLC3$00.00%

Sold out (24)

Institutions that held Immunovant, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.

Institutions that sold out of IMVT in Q2 2023
InstitutionShares, Q1 2023Value, Q1 2023
BVF Inc2,561,000$39.7M
Eventide Asset Management, LLC1,390,000$21.6M
Cowen and Company, LLC1,250,000$19.4M
Ikarian Capital, LLC774,398$12.0M
Boothbay Fund Management, LLC138,000$2.14M
Squarepoint Ops LLC93,895$1.46M
Jump Financial, LLC45,600$707.3K
Trexquant Investment LP34,184$530.2K
TD Asset Management Inc29,900$463.7K
Dynamic Technology Lab Private Ltd29,383$456.0K
Axq Capital, LP26,727$414.5K
Harvest Investment Services, LLC25,305$392.5K
Verition Fund Management LLC24,910$386.4K
Martingale Asset Management L P21,605$335.1K
XTX Topco Ltd20,548$318.7K
Virginia Retirement Systems Et Al19,000$294.7K
Quantbot Technologies LP14,437$223.9K
American Century Companies Inc13,352$206.6K
Fox Run Management, L.L.C.12,882$199.8K
Bailard, Inc.12,200$189.2K
PDT Partners, LLC11,779$182.7K
Values First Advisors, Inc.6,962$108.0K
TCI Wealth Advisors, Inc.226$3.51K
Parallel Advisors, LLC24$372